Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorVesalio
About this trial
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Eligibility criteria
Qualifiers
Age ≥22
Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
Vessel dilation procedure was performed with the NeVa VS
Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure
Disqualifiers
None
Trial design
Treatments tested in this trial
- NEVA VS
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
16California
Providence St. Joseph Medical Center91505, Burbank United States
John Muir Health94589, Walnut Creek United States
Connecticut
Yale06520, New Haven United States
Florida
Baptist Health South Florida33143, Miami United States
Sponsors and collaborators
Vesalio
Lead sponsor
Source ClinicalTrials.gov